Success Metrics

Clinical Success Rate
71.4%

Based on 5 completed trials

Completion Rate
71%(5/7)
Active Trials
1(8%)
Results Posted
40%(2 trials)
Terminated
2(17%)

Phase Distribution

Ph not_applicable
4
33%
Ph phase_3
1
8%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 3Large-scale testing
1(20.0%)
N/ANon-phased studies
4(80.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

1

trials recruiting

Total Trials

12

all time

Status Distribution
Active(1)
Completed(5)
Terminated(2)
Other(4)

Detailed Status

Completed5
unknown4
Terminated2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
1
Success Rate
71.4%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (20.0%)
N/A4 (80.0%)

Trials by Status

unknown433%
terminated217%
recruiting18%
completed542%

Recent Activity

1 active trials
Showing 5 of 12
completedphase_3

Risk of Stroke and Silent Cerebrovascular Thromboembolism After Cardioversion of Atrial Fibrillation

NCT01924065
recruiting

MANAGE-VT Registry - MANAGEment of Ventricular Tachycardia Outcomes Registry

NCT06455488
completed

Bursa Postgraduate Hospital Department of Cardiology

NCT05231967
completednot_applicable

Impact of New Biomarkers on Maintenance of Sinus Rhythm After Cardioversion or Ablation of Atrial Fibrillation

NCT03351816
unknown

P-wave Terminal Force in Patients With Atrial Fibrillation.

NCT03428971
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT01924065Phase 3

Risk of Stroke and Silent Cerebrovascular Thromboembolism After Cardioversion of Atrial Fibrillation

Completed
NCT06455488

MANAGE-VT Registry - MANAGEment of Ventricular Tachycardia Outcomes Registry

Recruiting
NCT05231967

Bursa Postgraduate Hospital Department of Cardiology

Completed
NCT03351816Not Applicable

Impact of New Biomarkers on Maintenance of Sinus Rhythm After Cardioversion or Ablation of Atrial Fibrillation

Completed
NCT03428971

P-wave Terminal Force in Patients With Atrial Fibrillation.

Unknown
NCT04155879Not Applicable

Atrial Fibrillation Recurrence Following Cardioversion: the Role of Clinical Factors and Alpha Defensin Levels

Unknown
NCT02742207

Renal Function Post Cardioversion for Atrial Fibrillation

Unknown
NCT02245009

Safety of External Electrocardioversion in Device Patients

Unknown
NCT01558128Not Applicable

Combined Amiodarone and Electrical Cardioversion for Postoperative Atrial Fibrillation After Cardiac Surgery

Terminated
NCT01229033Not Applicable

Ablating Atrial Tachycardias Occuring During Ablation of Complex Fractionated Electrograms in Persistent AF

Completed
NCT00590525

Inflammation as a Predictor in Cardioversion of Atrial Fibrillation

Completed
NCT00209911

Study of the Effect of Cardioversion on Cardiac Volume in Patients With Persistent Atrial Fibrillation

Terminated

All 12 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
12